Analysed SOLID BIOSCIENCES INC (SLDB:NASDAQ) News Sources
Solid Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
19-03-2026
yahoo.com
Solid Biosciences Announces Receipt of European Commission Orphan Drug Designation for SGT-003 for the Treatment of Duchenne Muscular Dystrophy
28-04-2026
yahoo.com
Solid Biosciences to Showcase a Large Presence at the 29th Annual Meeting of the American Society of Gene and Cell Therapy
30-04-2026
yahoo.com
Solid Biosciences Doses First Participant in Phase 3 IMPACT DUCHENNE Clinical Trial Evaluating SGT-003 in Duchenne Muscular Dystrophy
07-05-2026
yahoo.com
Solid Biosciences Reports First Quarter 2026 Financial Results and Provides Business Updates
12-05-2026
yahoo.com
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01-06-2026
yahoo.com
Solid Biosciences and NanoMosaic Announce Co-Marketing Agreement to Advance Gene Therapy Delivery and Analytics
02-06-2026
yahoo.com
What is the current price of SOLID BIOSCIENCES INC (SLDB:NASDAQ)?
The current price of SOLID BIOSCIENCES INC (SLDB:NASDAQ) is $7.15.
SOLID BIOSCIENCES INC (SLDB:NASDAQ) absolute price change since previous trading day?
The absolute price change of SOLID BIOSCIENCES INC (SLDB:NASDAQ) since the previous trading day is $-0.07.
SOLID BIOSCIENCES INC (SLDB:NASDAQ) percentage price change since previous trading day?
The percentage price change of SOLID BIOSCIENCES INC (SLDB:NASDAQ) since the previous trading day is -0.9695%.
What is the most recent average sentiment score for SOLID BIOSCIENCES INC (SLDB:NASDAQ)?
The most recent average sentiment score for SOLID BIOSCIENCES INC (SLDB:NASDAQ) is 71 out of 100.
What is the most recent average sentiment for SOLID BIOSCIENCES INC (SLDB:NASDAQ)?
The most recent sentiment for SOLID BIOSCIENCES INC (SLDB:NASDAQ) is .
SEC-8K** Filing Available For SOLID BIOSCIENCES INC (SLDB:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.